|
Secondary prevention
Citations 301-310 of 568 total displayed.
|
Past content
(since Feb 1999):
|
- Articles
Peroxisome Proliferator-Activated Receptor Ligand Bezafibrate for Prevention of Type 2 Diabetes Mellitus in Patients With Coronary Artery Disease
- Alexander Tenenbaum, Michael Motro, Enrique Z. Fisman, Ehud Schwammenthal, Yehuda Adler, Ilan Goldenberg, Jonathan Leor, Valentina Boyko, Lori Mandelzweig, and Solomon Behar
Circulation published May 3, 2004, doi:10.1161/01.CIR.0000126824.12785.B6
[Abstract]
- Review: Current Perspectives
Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype
- T.B. Twickler, G.M. Dallinga-Thie, J.S. Cohn, and M.J. Chapman
Circulation 2004;109:1918-1925, doi:10.1161/01.CIR.0000125278.58527.F3
[Full text]
- Clinician Update
High-Density Lipoprotein and Cardiovascular Risk
- Peter P. Toth
Circulation 2004;109:1809-1812, doi:10.1161/01.CIR.0000126889.97626.B8
[Full text]
- Clinical Investigations and Reports
Blood Pressure and Risk of Secondary Cardiovascular Events in Women: The Women’s Antioxidant Cardiovascular Study (WACS)
- Peter J. Mason, JoAnn E. Manson, Howard D. Sesso, Christine M. Albert, Marilyn J. Chown, Nancy R. Cook, Philip Greenland, Paul M Ridker, and Robert J. Glynn
Circulation 2004;109:1623-1629; published online before print as doi:10.1161/01.CIR.0000124488.06377.77
[Abstract]
[Full text]
- Clinical Investigations and Reports
Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy: Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients
- Thomas Wichter, Matthias Paul, Christian Wollmann, Tayfun Acil, Petra Gerdes, Obaidullah Ashraf, Tonny D.T. Tjan, Rasijd Soeparwata, Michael Block, Martin Borggrefe, Hans H. Scheld, Günter Breithardt, and Dirk Böcker
Circulation 2004;109:1503-1508; published online before print as doi:10.1161/01.CIR.0000121738.88273.43
[Abstract]
[Full text]
- Cardiology Patient Pages
Heart Disease Prevention in Women
- Lori Mosca
Circulation 2004;109:e158-160e, doi:10.1161/01.CIR.0000124449.48800.C3
[Full text]
- Articles
Blood Pressure and Risk of Secondary Cardiovascular Events in Women. The Women’s Antioxidant Cardiovascular Study (WACS)
- Peter J. Mason, JoAnn E. Manson, Howard D. Sesso, Christine M. Albert, Marilyn J. Chown, Nancy R. Cook, Philip Greenland, Paul M Ridker, and Robert J. Glynn
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000124488.06377.77
[Abstract]
- Clinical Investigations and Reports
Explaining the Decline in Coronary Heart Disease Mortality in England and Wales Between 1981 and 2000
- Belgin Unal, Julia Alison Critchley, and Simon Capewell
Circulation 2004;109:1101-1107; published online before print as doi:10.1161/01.CIR.0000118498.35499.B2
[Abstract]
[Full text]
- Articles
Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy. Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients
- Thomas Wichter, Matthias Paul, Christian Wollmann, Tayfun Acil, Petra Gerdes, Obaidullah Ashraf, Tonny D.T. Tjan, Rasijd Soeparwata, Michael Block, Martin Borggrefe, Hans H. Scheld, Günter Breithardt, and Dirk Böcker
Circulation published March 8, 2004, doi:10.1161/01.CIR.0000121738.88273.43
[Abstract]
- Clinical Investigations and Reports
Progression of Early Carotid Atherosclerosis Is Only Temporarily Reduced After Antibiotic Treatment of Chlamydia pneumoniae Seropositivity
- Dirk Sander, Kerstin Winbeck, Jürgen Klingelhöfer, Thorleif Etgen, and Bastian Conrad
Circulation 2004;109:1010-1015; published online before print as doi:10.1161/01.CIR.0000117232.30832.EC
[Abstract]
[Full text]
|
|
